Genoscience Pharma receives orphan drug designation for hepatocellular carcinoma drug
Genoscience Pharma has announced that its lead candidate, ezurpimtrostat, a PPT-1 (Palmitoyl Protein Thioesterase-1) inhibitor,…
Genoscience Pharma has announced that its lead candidate, ezurpimtrostat, a PPT-1 (Palmitoyl Protein Thioesterase-1) inhibitor,…
Phesi Inc., a global provider of clinical development data analytics, has published an analysis of…
By Michael Pisano, executive vice president, proteomics, Discovery Life Sciences In oncology, characterizing genetic markers…
Active Biotech has announced the completion of the phase I clinical study testing the safety…
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with…
A large clinical study is now beginning on an approved drug for treating psoriasis. The…
French biotech company Onxeo S.A. has given an update on the clinical development program of…
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
Digitization is changing the way clinical trials are conducted. Spurred by the pandemic, decentralized clinical…
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been…
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…